8Bekaii-Saab T, Bendell J C, Cohn A L, et al.Bevacizumab(BV) plus chemotherapy (CT) in second-line metastatic colorectal cancer(mCRC) : Initial results from ARIES, a second BV observational cohort study (OCS)[J]. J Clin Oncol, 2010, 28(suppl 15) : 3595.
9Guan Z, Xu J, Luo R, et al.Efficacy and safety of bevacizumab(BEV) plus chemotherapy in Chinese patients(pts) with metastatic colorectal cancer (mCRC) : Results from the ARTIST study[J].J Clin Oncol, 2010, 28(suppl 15) : 14002.
10Allegra C J, Yothers G, O' Connell M J, et al.Phase Ⅲ trial assessing bevacizumab in stages II and III carcinoma of the colon : Results of NSABP Protocol C-08[J].J Clin Oncol, 2011, 29(1) : 11-16.
7Rault A,Collet D,Sa Cunha A,et al.Surgical management of obstructed colonic cancer[J].Ann Chir,2005,130(5):311.
8Camunez F,Echenagusia A,Simo G,et al.Malignant colorectal obstruction treated by means of self-expanding metallic stents:effectiveness before surgery and in palliation[J].Radiology,2000,216(2):429.
9Mainar A,De Gregorio M A,Tejero E,et al.Acute colorectal obstruction:treatment with self-expandable metallic stents before scheduled surgery:results of a multicenter study[J].Radiology,1999,210(1):65.
10Morino M,Bertell A,Garbarini A,et al.Malignant colonic obstruction manage by endoscopic stent decompression followed by laparoscopic resections[J].Surg Endosc,2002,16:1483.
